戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  likely to receive cholesterol screening and bone densitometry.
2 quire risk factor information in addition to bone densitometry.
3 ors were significantly related to performing bone densitometry.
4  magnetic resonance (MR) imaging (2.6%), and bone densitometry (1.5%) (percentages do not add up to 1
5 thout low BMD underwent lumbar spine and hip bone densitometry and a complete periodontal examination
6                                              Bone densitometry and histomorphometry in lymphoma-beari
7 rved bone mass at 6 and 12 mo as measured by bone densitometry and histomorphometry.
8       It may help achieve appropriate use of bone densitometry and may allow convenient dissemination
9                                              Bone densitometry and micro-computed tomography (microCT
10 menopausal women were less likely to undergo bone densitometry and to receive a prescription medicati
11  who had recently (within 2 weeks) undergone bone densitometry and were found to have osteoporosis.
12 al glucocorticoids did not routinely undergo bone densitometry and/or receive prescription medication
13 ee percent of the study population underwent bone densitometry, and 42% were prescribed a medication
14 amination, spine magnetic resonance imaging, bone densitometry, and brain magnetic resonance angiogra
15 erol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship y
16 on analysis, with potential in arthrography, bone densitometry, and metastases surveillance.
17 microarchitecture and adds value to standard bone densitometry, and the Fracture Risk Assessment Tool
18  phenotyping included bone histomorphometry, bone densitometry by dual-energy x-ray absorptiometry, a
19 hysicians increased use and understanding of bone densitometry, changed management of osteoporosis, a
20                                 Clinical and bone densitometry (dual x-ray absorptiometry [DXA]) reco
21 ysical function, and bone measurements using bone densitometry (dual-energy x-ray absorptiometry), an
22 te among older men the cost-effectiveness of bone densitometry followed by 5 years of oral bisphospho
23                                              Bone densitometry followed by bisphosphonate therapy for
24 ive Services Task Force guidelines recommend bone densitometry for all women older than 65 years, ide
25 n women with epilepsy, studies investigating bone densitometry frequency and calcium and vitamin D su
26              A major barrier to wider use of bone densitometry has been a lack of reports that are co
27       Factors associated with not undergoing bone densitometry in adjusted logistic models included m
28 , and radiation-free approach may complement bone densitometry in assessing risk of osteoporotic frac
29 n the face of increasing use of all types of bone densitometry in the diagnosis and management of ost
30 isease burden, appropriate interpretation of bone densitometry (including the use of a female referen
31 d-type (WT) littermate mice was evaluated by bone densitometry, microcomputed tomography, and analysi
32                          All women underwent bone densitometry of the lumbar spine and hip.
33  screening tool either for early referral to bone densitometry or for occult spinal fractures.
34 elationship between calcium nephrolithiasis, bone densitometry scoring, and bone mineral density (BMD
35 nclude benefits and limitations of pediatric bone densitometry techniques, proper interpretation of t
36 d testing, cervical and colon screening, and bone densitometry) than matched controls.
37                                   The use of bone densitometry to diagnose and predict fracture risk
38                        Clinical reporting of bone densitometry to primary care physicians increased u
39 ffice laboratory monitoring, radiographs, or bone densitometry to supplement their income (i.e., down
40 ent (intervention 33% versus control 38%) or bone densitometry use (intervention 8% versus control 8%
41 use (intervention 32% versus control 34%) or bone densitometry use (intervention 9% versus control 5%
42                        Our data suggest that bone densitometry used for assessment of the condition o
43 e femoral neck were measured at baseline and bone densitometry was repeated after 3.5 years by dual-e